The first 1 mg engages more of the GIP receptor than the next 11 mg combined. GLP-1 appetite suppression continues to rise, but the added benefit narrows in the higher bands while side effects keep increasing
Drugs in R&D, 23(3), 257265
Weight loss and weight management GLP-1 therapy can produce clinically meaningful weight loss in older adults carrying excess weight, by reducing appetite and prolonging fullness so it is easier to eat less without constant hunger
This way of doing things is good for people who have ongoing issues like type 2 diabetes
Mounjaro is a once-weekly injectable medication that contains tirzepatide, a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist
Gia McCloskey-Jurevich, NP , provides individualized, knowledgeable care, helping you navigate the options to find what works best for your body